Ekadasa Madhumehara Ayurveda Churna for High Sugar

Pharmaceutico-Therapeutic Study of Madhumehantak Churna (Ayurveda Powder) for Diabetes

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/05/008673

Enrollment

100

Registered

2017-05-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Type 2 Diabetes Mellitus, with Hgb A1C 6.0%, age 30-65

Interventions

Intervention1: Madhumehantak Churna: Dose - 4g powder Frequency - thrice daily 20 minutes before food route of admin - oral, with warm water total duration of therapy - three months details of pow

Eligibility

Inclusion criteria

Inclusion criteria: 1. Hgb A1c greater than 7% 2. active informed consent

Exclusion criteria

Exclusion criteria: 1. malignant hypertension 2. pregnancy or impending pregnancy 3. lactating mothers 4. diabetic co-morbidity of nephropathy, coronary artery disease, thyroid disease, past history of cancer 5. surgery in the past 6 months

Design outcomes

Primary

Measure	Time frame
change in Hbg A1CTimepoint: time zero 3 months of use	—

Secondary

Measure	Time frame
complete use of interventionTimepoint: time zero 3 months of time	—

Countries

India

Contacts

Public ContactDr Bhaswati Bhattacharya

Banaras Hindu University

bhaswati@post.harvard.edu9838008600

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026